The current valuation score of Anavex Life Sciences Corp is 8.02, ranking 178 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.51, which is -3.91% below the recent high of -5.29 and -342.60% above the recent low of -24.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.